Home-based diabetes screening for women after gestational diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of community health workers (CHWs) in delivering home-based oral glucose tolerance tests (OGTT) to increase postpartum diabetes screening among women who had gestational diabetes in urban slums of Pune, India. The study compares two approaches: home testing by CHWs and referral for clinic-based screening. By implementing this model, the trial aims to improve early detection of type 2 diabetes mellitus in a high-risk population, potentially reducing morbidity and mortality. The trial will also assess the feasibility and acceptability of the CHW-led intervention in low-income settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Pregnant Women:

* Pregnant woman residing in one of pre-selected slum communities
* 18 years or older
* ≥ 24 weeks gestational age (as determined by self-reported last menstrual period or ultrasound)
* Meet or exceed the threshold for GDM as determined by the CHW-delivered fasting OGTT
* Agrees to study procedures, including in-person visits with the CHW postpartum if they are diagnosed with GDM

Community Health Workers:

* 18 years or older
* Willingness to participate in study procedures and recruit eligible pregnant women
* Agreement with goals of the study
* Resides in one of the study communities
* Willing to participate in surveys and interviews

Clinicians:

* 18 years or older
* Diabetes or obstetrics physicians
* In a patient-facing position for over 1 year

Ministry of Health Officials

* 18 years or older
* Employed by the Ministry of Health and Family Welfare, Maternal Health Division

Exclusion Criteria:

Pregnant Women:

* Preexisting diabetes diagnosis prior to current pregnancy
* Unable to tolerate food/ drink and remain fasting for 8 hoursUnwilling or unable to participate in study procedures
* Unwilling or unable to provide informed consent

CHW, Clinicians, Ministry of Health Officials

1. Unwilling or unable to participate in study procedures
2. Unwilling or unable to provide informed consent

Where it's running

• Deep Griha Society
  Pune, Maharashtra, India Recruiting

Study contacts

• Principal investigator: Jyoti Mathad, MD, MSc — Weill Cornell Medicine Center for Global Health
• Study coordinator: Jyoti S Mathad, MD, MSc
• Email: jsm9009@med.cornell.edu
• Phone: 646-962-8140

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing Insulin Detemir and NPH for Managing Diabetes in Pregnancy

  This study is testing whether insulin detemir or NPH is better for managing blood sugar in pregnant women with diabetes and if it affects the risk of low blood sugar in their newborns.

  Recruiting Phase 2 University of California, Los Angeles · Los Angeles, California · NCT05124457

• Proliverenol for liver fat and insulin resistance in type 2 diabetes

  This study tests whether adding Proliverenol to standard diabetes care can improve liver fat and blood sugar control in adults with type 2 diabetes.

  Recruiting Phase 2 Universitas Sriwijaya · Palembang, South Sumatera · NCT07928661

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Safety test of NNC9836-0001 in adults with overweight/obesity or type 2 diabetes

  This study tests whether the new medicine NNC9836-0001 is safe and tolerable in adults who are overweight or have type 2 diabetes, compared to placebo.

  Recruiting Phase 1 Novo Nordisk A/S · Neuss · NCT07896109

• RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes

  This study tests the accuracy and safety of the RIGHTEST iFree 2 continuous glucose monitor in pregnant adults with type 1, type 2, or gestational diabetes.

  Recruiting Bionime Corporation · Ulm, Baden-Wurttemberg · NCT07889388

• EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes

  This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.

  Recruiting Phase 3 Eli Lilly and Company · Tucson, Arizona and 74 other locations · NCT07881458

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.